Primer: Xunfei Healthcare Technology (XHT HK) - Aug 2026
Leading Player in a High-Growth Sector: Xunfei Healthcare is the largest AI-empowered healthcare solution provider in China, holding a 5.9%...
94 Views
CMCDI (133 HK): AGM Outcome May Provide Another Leg-Up
CMCDI is cheap. If small, illiquid names, with a activism angle are your thing, pick up shares here. Keep an eye on the AGM. If Kan is booted, this...
612 Views
Pre-IPO Hangzhou Diagens Biotechnology (PHIP Updates) - The IPO Pricing Is Expensive
​Diagens' IPO pricing has "overdrawn" the growth expectation for next two years, with valuation far exceeding peers.Comfortable P/S is 10x-15x,...
255 Views
Pre-IPO Hangzhou Diagens Biotechnology - The Turning Point of Medical Imaging AI Has Not Arrived
​Hospital/patients are not yet fully embracing medical AI, hindering commercialization.Diagens faces challenges in gaining recognition considering...
386 Views
Xunfei Healthcare - Government Remains the Primary Driving Force of Medical AI Applications
G-end business revenue increased 87% YoY to RMB141mn, and accounted for 30.4% of our full-year forecast, exceeding the historical average of ~28%.
324 Views